Carbetocin Injection Market Size and Share: 2031 Key Findings
The Carbetocin Injection Market is expected to register a CAGR of 7.9% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Type (Original Drug, Generic Drug). Futher, it is segmented based on End user (Hospitals, Clinics, Other). The global analysis is further broken-down at regional level and major countries. The report offers the value in USD for the above analysis and segments.
Purpose of the ReportThe report Carbetocin Injection Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Carbetocin Injection Market Segmentation
Type- Original Drug
- Generic Drug
- Hospitals
- Clinics
- Other
Strategic Insights
Carbetocin Injection Market Growth Drivers- Rise in Cesarean Sections and Postpartum Hemorrhage Cases: The increasing number of cesarean sections worldwide and the growing cases of postpartum hemorrhage (PPH) are the primary factors for the carbetocin injection market. Carbetocin, which is used to prevent and treat PPH, is a preferred choice because it reduces uterine bleeding and promotes postpartum recovery, thus creating a higher demand for this injectable drug.
- Preference for Carbetocin Over Oxytocin: Carbetocin is increasingly being used in place of oxytocin as it has a longer duration of action and lesser risk of side effects. It ensures better uterine contraction with lesser frequency of dosing. The management of postpartum hemorrhage has thus preferred carbetocin, which is driving its adoption and thus increasing the market demand.
- Growing Awareness of Maternal Health and Safety: Increased awareness of the topic of maternal health in order to avoid risks in which postpartum hemorrhage stands out, thus resulting in an increased demand for such effectual drugs as carbetocin. Improved healthcare offered by hospitals and medical centers ensures better maternal care, raising greater demand for carbetocin injections that may safely prevent excessive bleeding during deliveries.
- More Preferable Choice for Carbetocin Compared to Oxytocin: Carbetocin is being used more in comparison to oxytocin in preventing postpartum hemorrhage as it has a more prolonged duration of action and has lesser side effects. The use of carbetocin is growing for both cesarean and vaginal deliveries due to increasing demands of safer and effective alternatives of traditional oxytocin injections, hence fuelling market growth.
- Increasing Maternal Health and Safety Awareness: The growing consciousness with regard to maternal health and preventing the condition of postpartum hemorrhage is resulting in the growth of carbetocin injection market. Presently, healthcare structures throughout the world are directed at developing maternal care systems so that patients can safely undertake childbirth, and proper utilization of medicines such as carbetocin reduces bleeding, so, this medication is more and more in demand around the world.
- Government Support for Maternal Care: The increasing investment of governments and health institutions in maternal health and the improvement of maternal mortality rates are key to that investment. Carbetocin has emerged as an important tool in the management of postpartum hemorrhage. As global healthcare infrastructure develops, the demand for such a life-saving injection continues to rise, particularly in high-risk regions of developing nations.
- R&D: Application of research on carbetocin's alternative scope of uses from obstetric uses will lead to enormous business opportunities. Research steps can be easily understandable and can include the fact-finding inquiry into other beneficial therapeutic areas with special reference to cardiovascular and may be neurological Disorders. This will expose the area for some innovative treatment options that would prepare the product for wider market access as well as broaden Carbetocin's value proposition through newer options to create a more flexible option for providers to treat through increasing foot prints across different divisions of medicine arms.
- Engagement with Healthcare Professionals: Such strategic collaborations with health institutions, especially in the case of Carbetocin, will also add value in terms of credibility and penetration of this product in clinical practice given that they have structured training and education, which would facilitate the use of such novel knowledge in improving patient care. Thus, this would also create an avenue for creating therapeutic benefits of the product while allowing for collaborations that would sustain usage for a long time and contribute to the market penetration.
- Real Shift Invest towards Maternal Health: Carbetocin has thus created a rare business opportunity in the emerging global attention toward maternal health. More funds are being channeled toward maternal health, which ultimately leads to an increase in the demand for lifesaving effective treatment like that of Carbetocin to avert postpartum hemorrhage. This settlement would also translate to broader access in a market predominantly underdeveloped with regards to maternal health offerings, making Carbetocin a critical factor in improving maternal outcome across the globe.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Carbetocin Injection Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Carbetocin Injection Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Ferring Pharmaceuticals and Pfizer are some of the major players operating in the market.
The report provides an extensive qualitative and quantitative analysis of the current trends and future estimations of the global carbetocin injection market from 2021 to 2031, and it also determines the prevailing opportunities.
Asia Pacific region accounted for the highest CAGR in the carbetocin injection market.
The major factors driving the carbetocin injection market are:
1. Rising Demand for Uterotonics.
2. Innovations in Drug Composition.
North America region dominated the carbetocin injection market in 2023.
The Carbetocin Injection Market is estimated to witness a CAGR of 7.9% from 2023 to 2031
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Carbetocin Injection Market - By Type
1.3.2 Carbetocin Injection Market - By End-user
1.3.3 Carbetocin Injection Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CARBETOCIN INJECTION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CARBETOCIN INJECTION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CARBETOCIN INJECTION MARKET - GLOBAL MARKET ANALYSIS
6.1. CARBETOCIN INJECTION - GLOBAL MARKET OVERVIEW
6.2. CARBETOCIN INJECTION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. CARBETOCIN INJECTION MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ORIGINAL DRUG
7.3.1. Overview
7.3.2. Original Drug Market Forecast and Analysis
7.4. GENERIC DRUG
7.4.1. Overview
7.4.2. Generic Drug Market Forecast and Analysis
8. CARBETOCIN INJECTION MARKET - REVENUE AND FORECASTS TO 2028 - END-USER
8.1. OVERVIEW
8.2. END-USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. OTHER
8.5.1. Overview
8.5.2. Other Market Forecast and Analysis
9. CARBETOCIN INJECTION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Carbetocin Injection Market Overview
9.1.2 North America Carbetocin Injection Market Forecasts and Analysis
9.1.3 North America Carbetocin Injection Market Forecasts and Analysis - By Type
9.1.4 North America Carbetocin Injection Market Forecasts and Analysis - By End-user
9.1.5 North America Carbetocin Injection Market Forecasts and Analysis - By Countries
9.1.5.1 Canada Carbetocin Injection Market
9.1.5.1.1 Canada Carbetocin Injection Market by Type
9.1.5.1.2 Canada Carbetocin Injection Market by End-user
9.1.5.2 Mexico Carbetocin Injection Market
9.1.5.2.1 Mexico Carbetocin Injection Market by Type
9.1.5.2.2 Mexico Carbetocin Injection Market by End-user
9.1.5.3 US Carbetocin Injection Market
9.1.5.3.1 US Carbetocin Injection Market by Type
9.1.5.3.2 US Carbetocin Injection Market by End-user
9.2. EUROPE
9.2.1 Europe Carbetocin Injection Market Overview
9.2.2 Europe Carbetocin Injection Market Forecasts and Analysis
9.2.3 Europe Carbetocin Injection Market Forecasts and Analysis - By Type
9.2.4 Europe Carbetocin Injection Market Forecasts and Analysis - By End-user
9.2.5 Europe Carbetocin Injection Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Carbetocin Injection Market
9.2.5.1.1 Germany Carbetocin Injection Market by Type
9.2.5.1.2 Germany Carbetocin Injection Market by End-user
9.2.5.2 France Carbetocin Injection Market
9.2.5.2.1 France Carbetocin Injection Market by Type
9.2.5.2.2 France Carbetocin Injection Market by End-user
9.2.5.3 Italy Carbetocin Injection Market
9.2.5.3.1 Italy Carbetocin Injection Market by Type
9.2.5.3.2 Italy Carbetocin Injection Market by End-user
9.2.5.4 Spain Carbetocin Injection Market
9.2.5.4.1 Spain Carbetocin Injection Market by Type
9.2.5.4.2 Spain Carbetocin Injection Market by End-user
9.2.5.5 United Kingdom Carbetocin Injection Market
9.2.5.5.1 United Kingdom Carbetocin Injection Market by Type
9.2.5.5.2 United Kingdom Carbetocin Injection Market by End-user
9.2.5.6 Rest of Europe Carbetocin Injection Market
9.2.5.6.1 Rest of Europe Carbetocin Injection Market by Type
9.2.5.6.2 Rest of Europe Carbetocin Injection Market by End-user
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Carbetocin Injection Market Overview
9.3.2 Asia-Pacific Carbetocin Injection Market Forecasts and Analysis
9.3.3 Asia-Pacific Carbetocin Injection Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Carbetocin Injection Market Forecasts and Analysis - By End-user
9.3.5 Asia-Pacific Carbetocin Injection Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Carbetocin Injection Market
9.3.5.1.1 Australia Carbetocin Injection Market by Type
9.3.5.1.2 Australia Carbetocin Injection Market by End-user
9.3.5.2 China Carbetocin Injection Market
9.3.5.2.1 China Carbetocin Injection Market by Type
9.3.5.2.2 China Carbetocin Injection Market by End-user
9.3.5.3 India Carbetocin Injection Market
9.3.5.3.1 India Carbetocin Injection Market by Type
9.3.5.3.2 India Carbetocin Injection Market by End-user
9.3.5.4 Japan Carbetocin Injection Market
9.3.5.4.1 Japan Carbetocin Injection Market by Type
9.3.5.4.2 Japan Carbetocin Injection Market by End-user
9.3.5.5 South Korea Carbetocin Injection Market
9.3.5.5.1 South Korea Carbetocin Injection Market by Type
9.3.5.5.2 South Korea Carbetocin Injection Market by End-user
9.3.5.6 Rest of Asia-Pacific Carbetocin Injection Market
9.3.5.6.1 Rest of Asia-Pacific Carbetocin Injection Market by Type
9.3.5.6.2 Rest of Asia-Pacific Carbetocin Injection Market by End-user
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Carbetocin Injection Market Overview
9.4.2 Middle East and Africa Carbetocin Injection Market Forecasts and Analysis
9.4.3 Middle East and Africa Carbetocin Injection Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Carbetocin Injection Market Forecasts and Analysis - By End-user
9.4.5 Middle East and Africa Carbetocin Injection Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Carbetocin Injection Market
9.4.5.1.1 South Africa Carbetocin Injection Market by Type
9.4.5.1.2 South Africa Carbetocin Injection Market by End-user
9.4.5.2 Saudi Arabia Carbetocin Injection Market
9.4.5.2.1 Saudi Arabia Carbetocin Injection Market by Type
9.4.5.2.2 Saudi Arabia Carbetocin Injection Market by End-user
9.4.5.3 U.A.E Carbetocin Injection Market
9.4.5.3.1 U.A.E Carbetocin Injection Market by Type
9.4.5.3.2 U.A.E Carbetocin Injection Market by End-user
9.4.5.4 Rest of Middle East and Africa Carbetocin Injection Market
9.4.5.4.1 Rest of Middle East and Africa Carbetocin Injection Market by Type
9.4.5.4.2 Rest of Middle East and Africa Carbetocin Injection Market by End-user
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Carbetocin Injection Market Overview
9.5.2 South and Central America Carbetocin Injection Market Forecasts and Analysis
9.5.3 South and Central America Carbetocin Injection Market Forecasts and Analysis - By Type
9.5.4 South and Central America Carbetocin Injection Market Forecasts and Analysis - By End-user
9.5.5 South and Central America Carbetocin Injection Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Carbetocin Injection Market
9.5.5.1.1 Brazil Carbetocin Injection Market by Type
9.5.5.1.2 Brazil Carbetocin Injection Market by End-user
9.5.5.2 Argentina Carbetocin Injection Market
9.5.5.2.1 Argentina Carbetocin Injection Market by Type
9.5.5.2.2 Argentina Carbetocin Injection Market by End-user
9.5.5.3 Rest of South and Central America Carbetocin Injection Market
9.5.5.3.1 Rest of South and Central America Carbetocin Injection Market by Type
9.5.5.3.2 Rest of South and Central America Carbetocin Injection Market by End-user
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. CARBETOCIN INJECTION MARKET, KEY COMPANY PROFILES
11.1. FERRING PHARMACEUTICALS
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. HYBIO PHARMACEUTICAL
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. PFIZER
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BEACON PHARMACEUTICALS LTD.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. CHENGDU SHENGNUO BIOTECHNOLOGY
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. TIBET AIM PHARM INC (AIM PHARM)
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SGPHARMA
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SMOKIN JOE
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MDA INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TAJ PHARMACEUTICALS
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Ferring Pharmaceuticals
2. Hybio Pharmaceutical
3. Pfizer
4. Beacon Pharmaceuticals Ltd.
5. Chengdu Shengnuo Biotechnology
6. Tibet Aim Pharm Inc (Aim Pharm)
7. SGPharma
8. Smokin Joe
9. MDA INC.
10. Taj Pharmaceuticals
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For